مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

1,241
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

EFFICACY OF INTERFERON AND AMANTADIN FOR TREATMENT OF HEPATITIS IN MAJOR THALASEMIA AT CHILDREN’S MEDICAL CENTER, TEHRAN

Pages

  39-43

Abstract

 Background: MAJOR THALASSEMIA is relatively common in Iran and in looking of their need to recurrent transfusion; their high risk for acquisition of HCV is revealed. These patients also suffer form liver hemosiderosis that accelerate disease excursion to cirrhosis and hepatocellular carcinoma. In this study combined therapy with INTERFERON and AMANTADIN has been evaluated.Methods: This prospective clinical trail has been done on thalasemic patients that had been contaminated by HCV and had laboratory signs of hepatitis. During years of 81-82, 26 patients admitted at Children Mmedical Center with MAJOR THALASSEMIA and HCV hepatitis. Inclusion criteria were positive HCVRNA, high ALT and histologic evidence of hepatitis in liver biopsy and exclusion criteria were history of incomplete treatment any contraindication of IFN or AMANTADIN-emergence of drugs adverse reactions, to intending of these criteria 10 case of them had situation for treatment and follow-up.Results: In 10 cases, treatment with IFN α - 2b in doses 3 mu for every square meter of body surface three times in week subcutaneously and cap. AMANTADIN in doses 100 mg po B.d for 6 months was done and after it, 8 cases were negative for HCV-RNA (8%) and in 6 patients, ALT turned to normal (60%) and in 2 other case ALT decrease to lower than 50% of pretreatment value. None of them showed drug adverse reactions and response to therapy was better in lower ages. No relation between response to therapy and liver hemosiderosis, inflammation and sexuality was found.Conclusion: Combined therapy with IFN and AMANTADIN is effective in HCV treatment and for lower recurrence, treatment period longer than 24 wk, such as 48 wk is recommended.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    FALAHI, GH.H., IZADYAR, MINA, & FATHI, AFSHIN. (2007). EFFICACY OF INTERFERON AND AMANTADIN FOR TREATMENT OF HEPATITIS IN MAJOR THALASEMIA AT CHILDREN’S MEDICAL CENTER, TEHRAN. TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ), 64(10), 39-43. SID. https://sid.ir/paper/38964/en

    Vancouver: Copy

    FALAHI GH.H., IZADYAR MINA, FATHI AFSHIN. EFFICACY OF INTERFERON AND AMANTADIN FOR TREATMENT OF HEPATITIS IN MAJOR THALASEMIA AT CHILDREN’S MEDICAL CENTER, TEHRAN. TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ)[Internet]. 2007;64(10):39-43. Available from: https://sid.ir/paper/38964/en

    IEEE: Copy

    GH.H. FALAHI, MINA IZADYAR, and AFSHIN FATHI, “EFFICACY OF INTERFERON AND AMANTADIN FOR TREATMENT OF HEPATITIS IN MAJOR THALASEMIA AT CHILDREN’S MEDICAL CENTER, TEHRAN,” TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ), vol. 64, no. 10, pp. 39–43, 2007, [Online]. Available: https://sid.ir/paper/38964/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button